A preliminary study for constructing a bioartificial liver device with induced pluripotent stem cell-derived hepatocytes

BioMedical Engineering Online

Volumn 11, Issue , 2012, Pages

  Iwamuro, Masaya ^a   Shiraha, Hidenori ^a   Nakaji, Shuhei ^b   Furutani, Masumi ^c   Kobayashi, Naoya ^d   Takaki, Akinobu ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d Okayama Saidaiji Hospital   (Japan)

Author keywords

Antibody mediated rejection; Bioartificial liver system; Hepatocyte differentiation; Hollow fiber bioreactor; Induced pluripotent stem cells

Indexed keywords

ANTIBODY-MEDIATED REJECTION; BIOARTIFICIAL LIVER; HEPATOCYTES; HOLLOW FIBER BIOREACTOR; PLURIPOTENT STEM CELLS;

ARTIFICIAL ORGANS; ASSAYS; BIOCONVERSION; BIOREACTORS; CIRCULATING MEDIA; EMBEDDED SYSTEMS; MORPHOLOGY; POLYMERASE CHAIN REACTION; PORE SIZE; SCANNING ELECTRON MICROSCOPY; STEM CELLS; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; UREA;

CELL CULTURE;

IPS;

TISSUE SCAFFOLD;

ANIMAL; ARTICLE; ARTIFICIAL LIVER; CELL DIFFERENTIATION; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; EQUIPMENT; EQUIPMENT DESIGN; EQUIPMENT FAILURE; LIVER CELL; MOUSE; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; PILOT STUDY; PLURIPOTENT STEM CELL;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HEPATOCYTES; LIVER, ARTIFICIAL; MICE; ORGAN CULTURE TECHNIQUES; PILOT PROJECTS; PLURIPOTENT STEM CELLS; TISSUE SCAFFOLDS;

MLCS; MLOWN;

EID: 84870524438     PISSN: None     EISSN: 1475925X     Source Type: Journal    
DOI: 10.1186/1475-925X-11-93     Document Type: Article

References (33)

1. Nevens F, Laleman W. Artificial liver support devices as treatment option for liver failure. Best Pract Res Clin Gastroenterol 2012, 26:17-26. 10.1016/j.bpg.2012.01.002, 22482522.
2. Sharma R, Greenhough S, Medine CN, Hay DC. Three-dimensional culture of human embryonic stem cell derived hepatic endoderm and its role in bioartificial liver construction. J Biomed Biotechnol 2010, 2010:236147. 2821762, 20169088.
3. Saliba F. The molecular adsorbent recirculating system (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care 2006, 10:118. 10.1186/cc4825, 1550821, 16542471.
4. Hassanein TI, Tofteng F, Brown RS, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007, 46:1853-1862. 10.1002/hep.21930, 17975845.
5. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002, 36:949-958.
6. Rozga J, Malkowski P. Artificial liver support: quo vadis?. Ann Transplant 2010, 15:92-101.
7. Rifai K. Fractionated plasma separation and adsorption: current practice and future options. Liver Int 2011, 31(Suppl 3):13-15.
8. Nyberg SL. Bridging the gap: Advances in artificial liver support. Liver Transpl 2012, 19(Suppl 2):S10-S14. in process.
9. Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012, 11:243-249. 10.1016/S1499-3872(12)60155-6, 22672816.
10. Nyberg SL, Amiot B, Hardin J, Baskin-Bey E, Platt JL. Cytotoxic immune response to a xenogeneic bioartificial liver. Cell Transplant 2004, 13:783-791. 10.3727/000000004783983378, 15690980.
11. Poyck PP, Hoekstra R, van Wijk AC, Attanasio C, Calise F, Chamuleau RA, van Gulik TM. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver. Liver Transpl 2007, 13:589-598. 10.1002/lt.21090, 17394165.
12. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996, 24:1446-1451. 10.1002/hep.510240625, 8938179.
13. Sussman NL, Kelly JH. Improved liver function following treatment with an extracorporeal liver assist device. Artif Organs 1993, 17:27-30.
14. Millis JM, Cronin DC, Johnson R, Conjeevaram H, Conlin C, Trevino S, Maguire P. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact. Transplantation 2002, 74:1735-1746.
15. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: initial clinical experience. Artif Organs 1994, 18:390-396. 10.1111/j.1525-1594.1994.tb02221.x, 8037614.
16. 2nd Patzer JF, Campbell B, Miller R. Plasma versus whole blood perfusion in a bioartificial liver assist device. ASAIO J 2002, 48:226-233. 10.1097/00002480-200205000-00005, 12058994.
17. Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007, 2:3081-3089. 10.1038/nprot.2007.418, 18079707.
18. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872. 10.1016/j.cell.2007.11.019, 18035408.
19. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920. 10.1126/science.1151526, 18029452.
20. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317. 10.1038/nature05934, 17554338.
21. Yasunaga M, Tada S, Torikai-Nishikawa S, Nakano Y, Okada M, Jakt LM, Nishikawa S, Chiba T, Era T, Nishikawa S. Induction and monitoring of definitive and visceral endoderm differentiation of mouse ES cells. Nat Biotechnol 2005, 23:1542-1550. 10.1038/nbt1167, 16311587.
22. Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T, Shahid JM, Hassan RA, Hassan WA, Nakaji S, Nishikawa Y, Kondo E, Yamamoto K, Fox IJ, Kobayashi N. Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 2010, 19:841-847. 10.3727/096368910X508960, 20955659.
23. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976, 13:29-83.
24. Nedredal GI, Amiot BP, Nyberg P, Luebke-Wheeler J, Lillegard JB, McKenzie TJ, Nyberg SL. Optimization of mass transfer for toxin removal and immunoprotection of hepatocytes in a bioartificial liver. Biotechnol Bioeng 2009, 104:995-1003. 10.1002/bit.22450, 2866646, 19557829.
25. Mengel M, Husain S, Hidalgo L, Sis B. Phenotypes of antibody-mediated rejection in organ transplants. Transpl Int 2012, 25:611-622. 10.1111/j.1432-2277.2012.01484.x, 22533649.
26. Clatworthy MR, Espeli M, Torpey N, Smith KG. The generation and maintenance of serum alloantibody. Curr Opin Immunol 2010, 22:669-681. 10.1016/j.coi.2010.08.018, 20932734.
27. Baquerizo A, Mhoyan A, Kearns-Jonker M, Arnaout WS, Shackleton C, Busuttil RW, Demetriou AA, Cramer DV. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation 1999, 67:5-18. 10.1097/00007890-199901150-00003, 9921790.
28. Nyberg SL, Yagi T, Matsushita T, Hardin J, Grande JP, Gibson LE, Platt JL. Membrane barrier of a porcine hepatocyte bioartificial liver. Liver Transpl 2003, 9:298-305. 10.1053/jlts.2003.50024, 12619028.
29. Ohgawara H, Hirotani S, Miyazaki J, Teraoka S. Membrane immunoisolation of a diffusion chamber for bioartificial pancreas. Artif Organs 1998, 22:788-794. 10.1046/j.1525-1594.1998.06185.x, 9754467.
30. Shi XL, Zhang Y, Han B, Gu JY, Chu XH, Xiao JQ, Ren HZ, Tan JJ, Ding YT. Effects of membrane molecular weight cutoff on performance of a novel bioartificial liver. Artif Organs 2011, 35:E40-46. 10.1111/j.1525-1594.2011.01201.x, 21371057.
31. Zhang Y, Shi XL, Han B, Gu JY, Chu XH, Xiao JQ, Ren HZ, Tan JJ, Ding YT. The influence of membrane molecular weight cutoff on a novel bioartificial liver. Artif Organs 2012, 36:86-93. 10.1111/j.1525-1594.2011.01287.x, 21819437.
32. Yu Y, Liu H, Ikeda Y, Amiot BP, Rinaldo P, Duncan SA, Nyberg SL. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: Relevance to cellular therapies. Stem Cell Res 2012, 9:196-207. 10.1016/j.scr.2012.06.004, 22885101.
33. Soto-Gutiérrez A, Navarro-Alvarez N, Zhao D, Rivas-Carrillo JD, Lebkowski J, Tanaka N, Fox IJ, Kobayashi N. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc 2007, 2:347-356.